Fraunhofer Biotech-Enhanced Plant Growth to be Commercialized by Delaware Research Center
20-Oct-2004 -
IP2Revenues LLC (IP2R), an
Intellectual Property Commercialization & Licensing company, has signed a
contract with the Fraunhofer USA Center for Molecular Biotechnology (FhCMB) to
expedite commercialization of a proprietary technology developed by
Fraunhofer.
"We're very excited about this ...
biotechnology
collaborations
contract research
+5